About the faculty

 

Anna Johansson, PhD, is a biostatistician and epidemiologist at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. Her primary interests lie in reproductive epidemiology and cancer epidemiology, with a special focus on pregnancy factors and breast cancer. She also has a research interest in survival analysis and epidemiological study designs. Anna has co-authored more than 70 scientific publications. Anna has been involved in the teaching of survival analysis and Biostat 3 on several occasions, both as a lecturer and as a teaching assistant.

 

These Andersson is an Assistant Professor at the department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden. She got her PhD in 2013 from Karolinska Institutet on the topic of statistical methods for estimating population-based cancer patient survival. Her primary research interest is survival analysis and cancer epidemiology, and has lately focused on survival after hematological malignancies. Therese is an experienced teacher, and has been involved in Biostat III on several occasions.

 

Caroline Weibull is a biostatistics PhD student at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. Caroline has considerable experience and expertise with teaching survival analysis and Stata. Her PhD is in the fields of cancer and reproductive epidemiology.

 

Alex Ploner is an experienced senior biostatistician at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. He has extensive expience working as an applied biostatistician, including genetic analyses and cancer screening. Alex has considerable expertise with R, Stata and survival analysis.

 

Henrik Olsson is a biostatistics PhD student at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. He worked as an applied biostatistician MEB and KEP during 2013-2017, where he collaborated with medical researchers of different specialisations providing statistical consultancy on various independent epidemiological and biostatistical projects. His PhD is on prediction for prostate cancer. This is the second time that Henrik has been involved in Biostat 3.

 

Mark Clements is an associate professor in biostatistics at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. He has worked as a biostatistician in Sweden, Australia, the United Kingdom and New Zealand for both universities and government. His primary research interests lie in cancer epidemiology, survival analysis methods and simulation for cancer screening. Mark has co-authored more than 90 scientific publications and also developed R software for generalised survival models. He has taught survival analysis to a range of audiences.